Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
21 Jul 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212747
08 Sep 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212463
RLD : No
TE Code : BX
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : ALBUTEROL SULFATE
Dosage Strength : EQ 2MG BASE
Approval Date : 2019-03-15
Application Number : 210948
RX/OTC/DISCN : RX
RLD : No
TE Code : BX
RLD : No
TE Code : BX
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : ALBUTEROL SULFATE
Dosage Strength : EQ 4MG BASE
Approval Date : 2019-03-15
Application Number : 210948
RX/OTC/DISCN : RX
RLD : No
TE Code : BX
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : DAPAGLIFLOZIN
Dosage Strength : 5MG
Approval Date :
Application Number : 211523
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : DAPAGLIFLOZIN
Dosage Strength : 10MG
Approval Date :
Application Number : 211523
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AB
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : CAPSULE; ORAL
Proprietary Name : ELIGLUSTAT TARTRATE
Dosage Strength : EQ 84MG BASE
Approval Date : 2021-09-08
Application Number : 212463
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : EMPAGLIFLOZIN
Dosage Strength : 2.5MG
Approval Date :
Application Number : 212322
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : EMPAGLIFLOZIN
Dosage Strength : 10MG
Approval Date :
Application Number : 212322
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : TABLET; ORAL
Proprietary Name : EMPAGLIFLOZIN
Dosage Strength : 25MG
Approval Date :
Application Number : 212322
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : CAPSULE; ORAL
Proprietary Name : PALBOCICLIB
Dosage Strength : 100MG
Approval Date :
Application Number : 213152
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Aizant Drug Research Solutions Pvt. Ltd.
Dosage Form : CAPSULE; ORAL
Proprietary Name : PALBOCICLIB
Dosage Strength : 125MG
Approval Date :
Application Number : 213152
RX/OTC/DISCN :
RLD :
TE Code :
Services
Analytical
API & Drug Product Development
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?